Wegovy
PRODUCT · 22 article mentions
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the brand name Wegovy for weight management, weight loss, and the treatment of metabolic-associated steatohepatitis.
Wikipedia: https://en.wikipedia.org/wiki/Semaglutide
Wikidata: Q133859283
Recent mentions
- Wegovy weight-loss pills to be available for patients in UK to buy
- Weight loss drug users save over £400 on food as take-up triples
- Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why
- Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
- Weekly diabetes jab shown to reduce blood-sugar levels and body weight
- Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
- Weight-loss drugs may prevent thousands of knee replacements, study suggests
- Serena Williams, 44, to return to tennis in Queen's doubles
- Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
- Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight